Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Am J Hematol. 2021 Jan;96(1):E5-E8. doi: 10.1002/ajh.26010. Epub 2020 Oct 21.
Am J Hematol. 2021.
PMID: 32974944
Free article.
Clinical Trial.
No abstract available.
IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review.
Chhabra S, Jain S, Fowler A, Sedov V, Neppalli AK, Schandl CA, Lazarchick J.
Chhabra S, et al. Among authors: neppalli ak.
Ann Clin Lab Sci. 2017 Sep;47(5):611-619.
Ann Clin Lab Sci. 2017.
PMID: 29066491
Review.
Item in Clipboard
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Gandhi UH, Cornell RF, Lakshman A, Gahvari ZJ, McGehee E, Jagosky MH, Gupta R, Varnado W, Fiala MA, Chhabra S, Malek E, Mansour J, Paul B, Barnstead A, Kodali S, Neppalli A, Liedtke M, Narayana S, Godby KN, Kang Y, Kansagra A, Umyarova E, Scott EC, Hari P, Vij R, Usmani SZ, Callander NS, Kumar SK, Costa LJ.
Gandhi UH, et al. Among authors: neppalli a.
Leukemia. 2019 Sep;33(9):2266-2275. doi: 10.1038/s41375-019-0435-7. Epub 2019 Mar 11.
Leukemia. 2019.
PMID: 30858549
Free PMC article.
Item in Clipboard
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.
Costa LJ, Lin Y, Cornell RF, Martin T, Chhabra S, Usmani SZ, Jagannath S, Callander NS, Berdeja JG, Kang Y, Vij R, Godby KN, Malek E, Neppalli A, Liedtke M, Fiala M, Tian H, Valluri S, Marino J, Jackson CC, Banerjee A, Kansagra A, Schecter JM, Kumar S, Hari P.
Costa LJ, et al. Among authors: neppalli a.
Clin Lymphoma Myeloma Leuk. 2022 May;22(5):326-335. doi: 10.1016/j.clml.2021.10.013. Epub 2021 Oct 30.
Clin Lymphoma Myeloma Leuk. 2022.
PMID: 34840088
Item in Clipboard
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG; BMT CTN 1703 Investigators.
Bolaños-Meade J, et al.
N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943.
N Engl J Med. 2023.
PMID: 37342922
Free PMC article.
Clinical Trial.
Item in Clipboard
Effectiveness, Safety, and Cost Implications of Outpatient Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma.
Marini J, Maldonado A, Weeda E, Neppalli A, Hashmi H, Edwards K.
Marini J, et al. Among authors: neppalli a.
Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):351-357. doi: 10.56875/2589-0646.1038.
Hematol Oncol Stem Cell Ther. 2023.
PMID: 37363969
Item in Clipboard
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.
Usmani SZ, Schjesvold F, Oriol A, Karlin L, Cavo M, Rifkin RM, Yimer HA, LeBlanc R, Takezako N, McCroskey RD, Lim ABM, Suzuki K, Kosugi H, Grigoriadis G, Avivi I, Facon T, Jagannath S, Lonial S, Ghori RU, Farooqui MZH, Marinello P, San-Miguel J; KEYNOTE-185 Investigators.
Usmani SZ, et al.
Lancet Haematol. 2019 Sep;6(9):e448-e458. doi: 10.1016/S2352-3026(19)30109-7. Epub 2019 Jul 18.
Lancet Haematol. 2019.
PMID: 31327689
Clinical Trial.
Item in Clipboard
Cite
Cite